• OrbiMed entities reported purchases of 472,571 shares of Electra Therapeutics common stock in a joint Form 4 filing.
• Purchase prices ranged from $7.07 to $7.88 per share.
• Reported indirect holdings totaled 7,357,741 shares following the purchases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000985), on November 05, 2026, and is solely responsible for the information contained therein.